Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bifonazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 10/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | PLA2G1B | P04054 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | IDO1 | P14902 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bifonazole SCHEMBL1551534 | 1.00 | CYP17A1 (1.00) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| Bifonazole SCHEMBL1606037 | 1.00 | CYP17A1 (1.00) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| Bifonazole SCHEMBL7598897 | 1.00 | CYP17A1 (1.00) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| Bifonazole SCHEMBL394764 | 1.00 | CYP17A1 (1.00) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| SCHEMBL11349905 | 0.98 | CYP17A1 (1.00) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| SCHEMBL25873391 | 0.92 | CYP17A1 (0.85) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| SCHEMBL738495 | 0.91 | CYP19A1 (1.00) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| SCHEMBL24177881 | 0.91 | CYP17A1 (0.82) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| SCHEMBL11362753 | 0.91 | CYP17A1 (0.85) | CYP17A1MEN1NR1I2USP2ABCB11 | |
| SCHEMBL11353276 | 0.91 | CYP19A1 (0.91) | CYP17A1MEN1NR1I2USP2ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13851 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122031290-A | Percutaneous permeation promoting system and preparation method and application thereof | 北京工商大学 | 2026-05-15 | — | — | CN | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719384-A2 | COMPOUNDS WITH ANTIFUNGAL PROPERTIES | Trustees of Dartmouth College (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4680240-A1 | METHOD OF TREATING DISORDERS WITH SURF1 MALFUNCTION | Cure Mito Foundation (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| US-20250360082-A1 | ANTIFUNGAL SOLUTION, PREPARATION METHOD THEREFOR, AND USE THEREOF | Shanghai Skin Disease Hospital (CN) | 2025-11-27 | — | — | US | claimed |
| US-12478566-B2 | Color stable skin benefit compositions | CONOPCO, INC. (US) | 2025-11-25 | — | — | US | claimed |
| US-20250352486-A1 | NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS | UNIVERSITAT POLITÈCNICA DE VALÈNCIA (ES) | 2025-11-20 | — | — | US | claimed |
| WO-1987002580-A1 | FILM-FORMING, PHARMACEUTICAL VEHICLES FOR APPLICATION OF MEDICAMENTS TO NAILS, PHARMACEUTICAL COMPOSITIONS BASED ON THOSE VEHICLES, AND METHODS OF USING SAME | DERMATOLOGICAL PRODUCTS OF TEXAS (US) | 1987-05-07 | — | — | WO | claimed |
| WO-1987002219-A1 | ALPHA TOCOPHEROL-BASED VESICLES | THE LIPOSOME COMPANY, INC. (US) | 1987-04-23 | — | — | WO | claimed |
| WO-1986005977-A1 | STEROIDAL LIPOSOMES | THE LIPOSOME COMPANY, INC. (US) | 1986-10-23 | — | — | WO | claimed |
| EP-0186055-A2 | Antimycotic gel preparations | BAYER AG (DE) | 1986-07-02 | — | — | EP | claimed |
| EP-0085882-B1 | ANTIMYCOTIC TAMPONS WITH HIGH RELEASE OF ACTIVE AGENT | BAYER AG (DE) | 1986-04-23 | — | — | EP | claimed |
| EP-0055396-B1 | ANTIFUNGAL COMPOSITIONS WITH A HIGH RELEASE RATE OF THE DRUG AS AN ELASTIC LIQUID DRESSING | BAYER AG (DE) | 1985-01-23 | — | — | EP | claimed |
| EP-0054205-B1 | ANTI-FUNGAL COMPOSITION IN EMULSION FORM WITH A HIGHER RELEASE RATE OF THE DRUG | BAYER AG (DE) | 1985-01-16 | — | — | EP | claimed |
| EP-0055397-B1 | ANTIFUNGAL COMPOSITIONS WITH A HIGH RELEASE RATE OF THE DRUG AS AN ELASTIC LIQUID DRESSING | BAYER AG (DE) | 1984-08-22 | — | — | EP | claimed |
| US-4457938-A | AZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1984-07-03 | — | — | US | claimed |
| EP-0058887-B1 | ANTIFUNGAL COMPOSITIONS WITH A HIGHER RATE OF THE DRUG RELEASE AS A STICK | BAYER AG (DE) | 1984-04-11 | — | — | EP | claimed |